FOCUS
Web Focus: 50th Anniversary of Clonal Selection Theory
CST: PATH TO ACCEPTANCE
Top of pageVisualizing the effects of antigen affinity on T-dependent B-cell differentiation FREE
Robert Brink, Tri Giang Phan, Didrik Paus and Tyani D Chan
Immunol Cell Biol 86: 31-39; advance online publication, November 20, 2007; doi:10.1038/sj.icb.7100143
B cells flying solo FREE
Joanna Groom and Fabienne Mackay
Immunol Cell Biol 86: 40-46; doi:10.1038/sj.icb.7100142
The regulation of the B-cell gene expression programme by Pax5 FREE
Melissa L Holmes, Clare Pridans and Stephen L Nutt
Immunol Cell Biol 86: 47-53; advance online publication, November 13, 2007; doi:10.1038/sj.icb.7100134
Self/non-self discrimination and the problem of keeping T cells alive FREE
Jonathan Sprent and Jae-Ho Cho
Immunol Cell Biol 86: 54-56; advance online publication, December 11, 2007; doi:10.1038/sj.icb.7100139
What do we know about the mechanisms of elimination of autoreactive T and B cells and what challenges remain FREE
Andreas Strasser, Hamsa Puthalakath, Lorraine A O'Reilly and Philippe Bouillet
Immunol Cell Biol 86: 57-66; advance online publication, November 20, 2007; doi:10.1038/sj.icb.7100141
Autoimmunity since the 1957 clonal selection theory: a little acorn to a large oak FREE
Ian R Mackay
Immunol Cell Biol 86: 67-71; advance online publication, November 27, 2007; doi:10.1038/sj.icb.7100135
Quantitative and qualitative approaches to GOD: the first 10 years of the clonal selection theory FREE
Margaret A Jordan and Alan G Baxter
Immunol Cell Biol 86: 72-79; advance online publication, November 27, 2007; doi:10.1038/sj.icb.7100140
Antibody production by single cells-
G J V Nossal & Joshua Lederberg
Nature 181: 1419-1420; (1958); doi:10.1038/1811419a0
First paragraph & References | PDF (232K)
This paper was the first true test of a prediction of the clonal selection theory. Joshua Lederberg , a pioneer of bacterial genetics, was visiting Macfarlane Burnet at the Walter and Eliza Hall Institute in 1957. He became intrigued by the new theory and worked with a young Gus Nossal to examine whether one antibody secreting cell would only make one type of antibody, as predicted.
The thymus and the precursors of antigen reactive cells-
J F A P Millar & G F Mitchell
Nature 216: 659-663; (1967); doi:10.1038/216659a0
Abstract & References | PDF (590K)
JF Miller was the first to show that the thymus played a role in development of lymphocytes involved in cell mediated responses. Here Miller and Mitchell show that the antibody producing cell is not from the thymus, but needs to collaborate with such cells to make antibody.
Specific Inactivation of Antigen-reactive Cells with 125I-Labelled Antigen-
G L Ada & Pauline Byrt
Nature 222: 1292-1292; (1969); doi:10.1038/2221291a0
First paragraph & References | PDF (264K)
GL Ada worked with Nossal in exploring the features of the clonal selection theory. In this paper Gordon Ada reported his hot-antigen suicide experiment. Heavily iodinated antigen served to delete antigen specific cells providing support for a large repertoire of different clones.
Continuous cultures of fused cells secreting antibody of predefined specificity-
G Köhler & C Milstein
Nature 256: 495-497; (1975); doi:10.1038/256495a0
First paragraph & References | PDF (759K)
The two authors of this paper would win the Nobel prize for Medicine in 1984 for the introduction of the 'monoclonal antibody'. By immortalizing the antibody secreting cell the paper established a profoundly important practical technique and left no doubt that only one type of antibody was made by a single B cell.
Somatic generation of antibody diversity-
Susumu Tonegawa
Nature 302: 575-581; (1983); doi:10.1038/302575a0
Abstract & References | PDF (847K)
In 1976 Susumu Tonegawa published his ground-breaking studies of genetic rearrangement in PNAS that contributed to the molecular mechanism of randomizing the antibody genes. A series of many papers followed including the papers from key laboratories in the field included here. Tonegawa was awarded the Nobel prize in 1987.
V and C parts of immunoglobulin
-chain genes are separate in myeloma-
Gaston Matthyssens & Susumu Tonegawa
Nature 273: 763-765; (1978); doi:10.1038/273763a0
Rearrangement of genetic information may produce immunoglobulin diversity-
M Weigart, L Gatmaitan, E Loh, J Schilling & L Hood
Nature 276: 785-790; (1978); doi:10.1038/276785a0
Identical 3' non-coding sequences in five mouse Ig
chain mRNAs favour a unique C
gene-
Nicholas M Gough, Suzanne Cory & Jerry M Adams
Nature 281: 394-396; (1979); doi:10.1038/281394a0
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins-
Stephen M Hedrik, David I Cohen, Ellen A Nielsen & Mark M Davis
Nature 308: 149-153; (1984); doi:10.1038/308149a0
Abstract & References | PDF (603K)
The nature of the T cell receptor proved elusive until this study and the one below by Steve Hedrick and Mark Davis revealed a structure related to B cell immunoglobulin
Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins-
Stephen M Hedrik, Ellen A Nielsen, Joshua Kavaler, David I Cohen & Mark M Davis
Nature 308: 153-158; (1984); doi:10.1038/308153a0
Induction of self-tolerance in mature peripheral B lymphocytes-
Christopher C Goodnow, Jeffrey Crosbie, Helle Jorgensen, Robert A Brink & Antony Basten
Nature 342: 385-391; (1989); doi:10.1038/342385a0
Abstract & References | PDF (770K)
A series of papers in the late 80s and early 90s used transgenic methods to explore the fate of self reactive B cells. Soluble self antigens causes slow loss and functional inactivation (anergy) whereas stronger antigens such as MHC and membrane anchored proteins induced the marked loss of the developing cells in an immature state.
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes-
David A Nemazee & Kurt Bürki
Nature 337: 562-566; (1989); doi:10.1038/337562a0
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens-
Suzanne B Hartley, Jeffrey Crosbie, Robert Brink, Aaron B Kantor, Antony Basten & Christopher C Goodnow
Nature 353: 765-769; (1991); doi:10.1038/353765a0
TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases-
Marc Feldmann & Ravinder N Maini
Nature Medicine 9: 1245-1250; (2003); doi:10.1038/nm939
Monoclonal antibodies have become a multi-billion dollar therapeutic industry. They are particularly effective in treating autoimmune conditions and some cancers.
Design of effective immunotherapy for human autoimmunity-
Marc Feldmann & Lawrence Steinman
Nature 435: 612-619; (2005); doi:10.1038/nature03727
